FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/074121 [Registered on: 20/09/2024] Trial Registered Prospectively
Last Modified On: 20/09/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Research utilizing Artificial Intelligence software in Ultrasound machines to improve fetal imaging 
Scientific Title of Study   Role of Artificial Intelligence in Fetal Imaging Workflows, Prospective evaluation 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr K Aparna Sharma 
Designation  Professor 
Affiliation  AIIMS New Delhi 
Address  Room No. 711, Mother and Child Block, Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, Ansari Nagar

South
DELHI
110029
India 
Phone  9711824415  
Fax    
Email  kaparnasharma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr K Aparna Sharma 
Designation  Professor 
Affiliation  AIIMS New Delhi 
Address  Room No. 711, Mother and Child Block, Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, Ansari Nagar

South
DELHI
110029
India 
Phone  9711824415  
Fax    
Email  kaparnasharma@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr K Aparna Sharma 
Designation  Professor 
Affiliation  AIIMS New Delhi 
Address  Room No. 711, Mother and Child Block, Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, Ansari Nagar

South
DELHI
110029
India 
Phone  9711824415  
Fax    
Email  kaparnasharma@gmail.com  
 
Source of Monetary or Material Support  
Origin Medical Research Lab, #644, 2/3/4 Floor, 12th Cross Road, 27th main road, Sector-1 HSR Layout,Bengaluru, Karnataka, India, PIN-560102  
 
Primary Sponsor  
Name  Origin Medical Research Lab, India 
Address  #644, 2/3/4 Floor, 12th Cross Road, 27th main road, Sector-1 HSR Layout,Bengaluru, Karnataka-560102 
Type of Sponsor  Other [Healthcare and Life Sciences Company] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr K Aparna Sharma  All India Institute of Medical Sciences  Department of Obstetrics and Gynaecology & Department of Radiology, All India Institute of Medical Sciences, New Delhi, Ansari Nagar-110029
South
DELHI 
09711824415

kaparnasharma@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee All India Institute Of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O00-O9A||Pregnancy, childbirth and the puerperium,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  1. Normal and Singleton pregnancies with no clinical indications of fetal anomaly prior to the exam
2. Gestational age between 11weeks+ 0 days to 13 weeks +6 days by last menstrual date(LMP) or ultrasound report if uncertain LMP 
 
ExclusionCriteria 
Details  1. Multiple pregnancies
2. Non-readable images(i.e., images with excessive shadows) 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Evaluate the diagnostic agreement between OMEA(Origin Medical Exam Assistant, a browser-based software as a medical device)- assisted examinations and traditional examinations
2. Assess the precision of fetal/obstetric measurements obtained with OMEA compared to standard practices
3. Determine the feasibility of introducing OMEA in the real-clinical setting 
Gestational age of fetus between 11 to 13 weeks and 6 days 
 
Secondary Outcome  
Outcome  TimePoints 
1. In accordance with practice guidelines, Sensitivity and Specificity of the OMEA in :
a) Detecting diagnostic views from obstetric ultrasound examinations
b) Identifyin anatomical structures/landmarks within the diagnostic views from obstetric ultrasound examinations
c) Annonating the anatomical structures/landmarks identified within the diagnostic views
d) Determinig the quality criteria required for clinical evaluation of diagnostic views

2.Reproducibility and repeatability of the OMEA in performing obstetric measurements

3. Workflow efficiency of OMEA for obstetric measurements performed on obstetric ultrasound examinations at relevant anatomical landmarks 
Gestational age of fetus between 11 to 13 weeks and 6 days 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Antenatal ultrasonography aids in assessing the growth of the fetus along with the birth abnormalities, enabling the fetus to receive timely and effective treatment before or after the delivery. Origin Medical Exam Assistant(OMEA) is a browser-based software as a medical device(SaMD) intended to aid Healthcare professionals(HCPs) in the analysis and interpretation of fetal/obstetric images and clips using Artificial Intelligence(AI)/Machine learning(ML) algorithms in real-time during fetal/obstetric examinations.

In traditional fetal ultrasound imaging, multiple factors affect the accuracy of the ultrasound examination, such as high fetal mobility, excessive maternal abdominal thickness, HCP’s skills and experience, and inter-observer variability. Moreover, the traditional fetal ultrasound significantly impacts the clinical workflow by increasing the workload leading to longer examination times, causing diagnostic delays that negatively impact patient outcomes, necessitating more equipment and highly trained HCPs.

Recent advancements in AI/ML are revolutionizing the field of radiology by augmenting the capabilities of HCPs, improving diagnostic accuracy and enhancing patient care outcomes.

 
Close